CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 105 enrolled
Drug / intervention
cholecalciferol (vitamin D) +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00681590
NCT00681590Phase 3Completed
CompareCT.gov

Safety of Vitamin D Supplementation in the Elderly

University of Miami·interventional·Posted May 21, 2008·Updated Jan 26, 2017

In Brief

A Phase 3 clinical trial evaluating cholecalciferol (vitamin D) for Vitamin D Deficiency. Completed, enrolled 105 participants across 1 site.

Detailed Summary

This study will evaluate the safety over 6 months of two different doses of vitamin D (cholecalciferol) in men and women age 65 and older. It will also evaluate if supplementation with vitamin D improves physical performance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVitamin D Deficiency
CountriesUnited States
CollaboratorsMerck Sharp & Dohme LLC

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 21, 2008
Enrollment StartApr 1, 2008
Primary CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 18.1 years ago

Interventions

cholecalciferol (vitamin D)dietary

400 IU daily (low dose)

cholecalciferol (vitamin D)dietary

2000 IU daily (high dose)